AccessPak for HIV PEP Expanded with Kaletra and Infliximab-abda Intravenous
Determining the interaction of AccessPak for HIV PEP Expanded with Kaletra and Infliximab-abda Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: emtricitabine / lopinavir / ritonavir / tenofovir
Brand name: AccessPak for HIV PEP Expanded with Kaletra
Synonyms: n.a.
Generic Name: infliximab
Brand name: Inflectra, Remicade, Renflexis
Synonyms: Infliximab, InFLIXimab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- AccessPak for HIV PEP Expanded with Kaletra-Infliximab-dyyb
- AccessPak for HIV PEP Expanded with Kaletra-Infliximab-dyyb Intravenous
- AccessPak for HIV PEP Expanded with Kaletra-Infliximab-qbtx Intravenous
- AccessPak for HIV PEP Expanded with Kaletra-Influenza A (H1N1) 2009 Monovalent Vaccine
- AccessPak for HIV PEP Expanded with Kaletra-Influenza A H1N1 Intranasal
- AccessPak for HIV PEP Expanded with Kaletra-Influenza A Vaccine
- Infliximab-abda Intravenous-AccessPak for HIV PEP Expanded with Viracept
- Infliximab-abda Intravenous-Accolate
- Infliximab-abda Intravenous-Accretropin
- Infliximab-abda Intravenous-Accucaine
- Infliximab-abda Intravenous-AccuHist Drops
- Infliximab-abda Intravenous-AccuHist PDX Drops